子宫血清癌的分子预后因素:系统性审查
Anna Svarna1, Michalis Liontos1, Alkistis Papatheodoridi1
1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, V.Sofias 80, 11528 Athens, Greece.
Current oncology (Toronto, Ont.)
|May 27, 2025
概括
子宫血清癌是一种罕见的子宫内膜癌亚型,具有独特的分子特征,如TP53突变. 识别这些分子特征可以指导个性化治疗策略,以获得更好的患者结果.
科学领域:
- 妇科瘤学 妇科瘤学
- 分子病理学分子病理学
- 癌症基因组学 癌症基因组学
背景情况:
- 子宫血清癌 (USC) 是子宫内膜癌的一个攻击性亚型.
- USCs的特点是TP53突变和广泛的副本数量改变.
- 它们被归类为副本数高/p53abn分子预后组.
研究的目的:
- 系统地审查和识别子宫血清癌的预后意义的分子特征.
- 为USC患者制定量身定制的治疗策略提供信息.
主要方法:
- 在PubMed/Medline和Cochrane数据库中进行了全面的文献搜索.
- 包括95项在2025年2月之前以英语出版的研究.
- 分子特征和癌症特征的识别和编目.
主要成果:
- 总共有66个不同的分子特征被确定.
- 发现了具有潜在预后影响的新癌症特征.
- 进一步强调了USC独特的分子形状.
结论:
- 识别的分子概况为USC的行为和治疗反应提供了洞察力.
- 结果可以为制定量身定制的治疗策略的临床实践提供信息.
- 这项研究旨在改善患有挑战性子宫血清癌的患者的治疗结果.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.2K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
381
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
